188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
Safety and immunogenicity of commercial Hepatitis B vaccines. |
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults |
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. |
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. |
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults |
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults |
99mTc-marked 14F7 MaB in metastatic breast, phase II |
14F7 MAb marked with Tc99 Phase II in breast tumors. |
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. |
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. |
THERESA |
Autologous graft in extensive myomectomies |
Gallbladder retractor and Knot pusher with simultaneous coaxial traction : new laparoscopic instruments. |
THERESA-2 Study |
CIGB500 in healthy volunteers |